All UK Cancer Patients Will Get Information on Clinical Trials
Health officials in the United Kingdom are implementing a new program to ensure patients with cancer and other serious diseases are kept better informed about ongoing clinical research related to their condition.
The goal of this new government program is to increase patient awareness about clinical trials taking place to advance medical research. The program calls for all patients to be routinely informed about scientific studies relevant to their case.
In addition to keeping individuals updated on new treatment options, the initiative also seeks to make it easier for patients who meet study criteria to participate in clinical trials.
Health Secretary Alan Johnson announced his plans for the new program at a summit hosted by the Prime Minister commemorating 60 years of research by the National Health Service. During his speech, Secretary Johnson praised the contributions of past patients, clinicians and scientists whose research efforts have helped ensure the health of today’s population. When asked about this new initiative, the head of the UK’s leading cancer charity had this to say,
“It shows a commitment to provide more information about the health research taking place in this country, and to involve and recruit more patients in clinical trials. This is good news for patients, both now and in the future.”
Harpal Kumar
Chief Executive, Cancer Research UK
If you’re a cancer patient in the United States who’d like to learn more about clinical trials being conducted both here and abroad, you can ask your oncologist or visit http://clinicaltrials.gov/.
Source: Cancer Research UK News
Related Podcast: What Are Clinical Trials? on Cancer.Net by the American Society of Clinical Oncology
Technorati Tags: cancer awareness; health reform; England; outreach programs; patient-centered care; public health education; volunteers
Print This
|
|
No Comments »
No comments yet.
RSS feed for comments on this post. TrackBack URI
Leave a comment
Browse All Categories: Next article: First Head and Neck Cancer Gene Therapy Faces FDA Review
Previous article: Berkeley Microarray Makes Cancer Diagnosis Less Costly
